2016
Gökbuget N, Kelsh M , Chia V, Advani A, Bassan R, Dombret H, et al. 2016. Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia. Blood Cancer J 6(9):e473.
View Abstract
Topics: Cancer
De Flora S, Camoirano A, Micale RT, La Maestra S, Savarino V, Zentilin P, Marabotto E, Suh M , Proctor DM. 2016. Reduction of hexavalent chromium by fasted and fed human gastric fluid. I. Chemical reduction and mitigation of mutagenicity. Toxicol Appl Pharmaco l 306(Sept 1):113-119; doi: 10.1016/j.taap.2016.07.004 . PMID: 27404458.
View Abstract
Topics: chromium
Kirman CR, Suh M , Hays SM, Gürleyük H, Gerads R, De Flora S, Parker W, Lin S, Haws LC, Harris MA, Proctor DM. 2016. Reduction of hexavalent chromium by fasted and fed human gastric fluid. II. Ex vivo gastric reduction modeling. Toxicol Appl Pharmacol 306(Sep 1):120-133; doi: 10.1016/j.taap.2016.07.002 . PMID: 27396814.
View Abstract
Topics: chromium
Suh M , Thompson CM, Brorby GP, Mittal L, Proctor DM. 2016. Inhalation cancer risk assessment of cobalt metal. Regul Toxicol Pharm 79(Aug):74-82; doi: 10.1016/j.yrtph.2016.05.009 . PMID: 27177823.
View Abstract
Topics: Cancer , cobalt , Metals , risk assessment
Jensen I , Zacherle E, Blanchette C, Zhang J, Yin W. 2016. Evaluating cost benefits of combination therapies for advanced melanoma. Drugs Context 5:212297; doi: 10.7573/dic.212297 .
View Abstract
Topics: Health Economics and Outcomes Research (HEOR)
Wang A, Richhariya A, Gandra SR, Calimlim B, Quek RGW, Nordyke RJ , Toth P. 2016. Systematic review of LDL-C apheresis for the treatment of familial hypercholesterolemia. J Am Heart Assoc 5(7):e003294; doi: 10.1161/JAHA.116.003294 . PMID: 27385428.
View Abstract
Topics: Epidemiology
Jensen IS , Wu C, Fan W, Lodise T, Nicolau, DP, DuFour S, Cyr PL , et al. 2016. Use of oritivancin in moderate-severe ABSSSI patients requiring IV antibiotics: US hospital budget impact analysis. J Manag Care Spec Pharm 22(6):752-64; doi: 10.18553/jmcp.2016.22.6.752 .
View Abstract